Live Breaking News & Updates on Global Phase

Stay updated with breaking news from Global phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)

AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , United-kingdom , Cambridge , Cambridgeshire , Japan , Christophe-hotermans , Sarah-walters , Waddington-cruz , World-analysis-utilizing-electronic-health-records , Electronic-health-records-database-analysis

Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma

Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

China , Taicang , Hebei , San-diego , California , United-states , Zheng-wei , Anhui , American , Edward-kerwin , Tim-mccarthy , Company-greater-china

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Belgium , Switzerland , Lin-chang , Sichuan , China , Boston , Leuven , Region-flamande , Japan , New-york

Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications

Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Meldola , Emilia-romagna , Italy , Germany , Peter-fasching , Dino-amadori , Helmy-eltoukhy , Nicola-normanno , Nasdaq , Facebook , Breast-cancer-center , D-product-service

Guardant Health, Inc.: Guardant Health Receives EU IVDR Certification for Guardant360 CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications

Blood-based test for comprehensive genomic profiling of solid cancers meets requirements under stricter EU In Vitro Diagnostic Regulation IVDR certification from TÜV SÜD enables broader adoption ....

Meldola , Emilia-romagna , Italy , Germany , Michael-weist , Nicola-normanno , Zarak-khurshid , Dino-amadori , Helmy-eltoukhy , Peter-fasching , Gynecological-cancer-center , Nasdaq